tgvtherapeutics.com
«Mul-1867: a Novel Inhaled Antibiotic »
  • Home
  • About Us
    • Overview
    • Management
    • Advisory Board
    • Investors
  • Products
    • Mul-1867
      • Cystic Fibrosis
      • Chronic Obstructive Pulmonary Disease
      • Ventilator-Associated Pneumonia
      • Fungal Pneumonia
    • Orphan Drug Candidates
      • Cystic Fibrosis
      • Fungal Pneumonia
  • Partnering
    • Partnering with TGV Therapeutics
    • Selected Partnership
  • Newsroom
  • Contact

  • «Mul-1867: a Novel Inhaled Antibiotic »

tgvtherapeutics.comHome

tgvtherapeutics.com

«Mul-1867: a Novel Inhaled Antibiotic »

© Copyright 2017 tgvtherapeutics.com / WordPress Theme by minti
top